OpenAlex
PricingAboutJobs
Log inGet started
Work

What Is the Right Dose? The Elusive Optimal Biologic Dose in Phase I Clinical Trials

HTML

Year: 2006
Type: editorial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2006.07.4658
Author: Alex A. Adjei
Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)
Language: English

Topic: Statistical Methods in Clinical Trials
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Keywords: enzastaurin, target plasma concentration, plasma protein binding, interindividual variability, dose selection, maximum tolerated dose, anticancer agents, recommended phase 2 dose, dose-limiting toxicity, small-molecule kinase inhibitors, antitumor efficacy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2161531371
Cites: 7
Cited by: 104
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security